Please Wait
Applying Filters...
menu
    • menu

    Digital Content for BEDAQUILINE FUMARATE

    Client Email Product
    Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    BEDAQUILINE FUMARATE

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 9,837Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    J&J Reduces Sirturo Price In South Africa, Ending Antitrust Probe
    J&J Reduces Sirturo Price In South Africa, Ending Antitrust Probe

    09 Jul 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/jj-agrees-40-price-cut-tuberculosis-med-sirturo-south-africa-ending-antitrust-probe

    FIERCE PHARMA
    09 Jul 2024
    Share Share
    J&J's tuberculosis Sirturo lands full US, EU approvals
    J&J's tuberculosis Sirturo lands full US, EU approvals

    08 Jul 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/jjs-tuberculosis-med-sirturo-lands-full-us-european-approvals-after-more-decade

    FIERCE PHARMA
    08 Jul 2024
    Share Share
    Janssen Submits Phase 3 Study Data to the EMA and FDA for SIRTURO
    Janssen Submits Phase 3 Study Data to the EMA and FDA for SIRTURO

    07 Nov 2023

    // PRESS RELEASE

    https://www.jnj.com/janssen-submits-phase-3-study-data-to-the-european-medicines-agency-and-u-s-food-and-drug-administration-for-sirturo-bedaquiline

    PRESS RELEASE
    07 Nov 2023
    Share Share
    After pubic pressure, J&J says it won't enforce Sirturo patents
    After pubic pressure, J&J says it won't enforce Sirturo patents

    02 Oct 2023

    // Zoey Becker FIERCE PHARMA

    https://www.fiercepharma.com/pharma/johnson-johnson-commits-not-enforce-secondary-patents-tuberculosis-med-sirturo

    Zoey Becker FIERCE PHARMA
    02 Oct 2023
    Share Share
    J&J, Lupin reduce price of TB drug bedaquiline in poor countries
    J&J, Lupin reduce price of TB drug bedaquiline in poor countries

    01 Sep 2023

    // Kevin Dunleavy FIERCE PHARMA

    https://www.fiercepharma.com/pharma/johnson-johnson-slashes-price-tuberculosis-drug-sirturo-after-relinquishing-patent

    Kevin Dunleavy FIERCE PHARMA
    01 Sep 2023
    Share Share
    J&J loses attempt to extend patent in India for tuberculosis drug
    J&J loses attempt to extend patent in India for tuberculosis drug

    23 Mar 2023

    // ENDPTS

    https://endpts.com/jj-loses-attempt-to-extend-patent-in-india-for-tuberculosis-drug/

    ENDPTS
    23 Mar 2023
    Share Share